NCT05879614 An Open-Label Study of Oral NNZ-2591 in Prader-Willi Syndrome (PWS-001) Status WITHDRAWN Phase PHASE2
NCT05791604 The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and Probiotics Status RECRUITING Phase NA
NCT05783791 Development of a Newborn Screening Assay for Angelman Syndrome and Prader-Willi Syndrome Status COMPLETED Phase N/A
NCT05778032 Biological Age Assessment in Adults With Prader-Willi Syndrome (ETABIOLPWS) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05761184 Characterization of Serum Proteome in Subjects With Prader Willi Syndrome (PROTEOMARKER) Status COMPLETED Phase N/A
NCT05701774 Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05657860 Guanfacine Extended Release for the Reduction of Aggression and Self-injurious Behavior Associated With Prader-Willi Syndrome Status COMPLETED Phase PHASE4
NCT05541003 Understanding the Role of Gut Microbiota in Hyperphagia in Prader-Willi Syndrome Status COMPLETED Phase PHASE2
NCT05504395 A Pharmacokinetic and Safety Study of CSTI-500 in Subjects With Prader-Willi Syndrome Status COMPLETED Phase PHASE1
NCT05387798 A Phase 3 Extension Study of RAD011 (Cannabidiol Oral Solution) in Patients With Prader-Willi Syndrome Status WITHDRAWN Phase PHASE3
NCT05322096 Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome Status COMPLETED Phase PHASE2
NCT05298085 Effect of Intranasal Oxytocin on Dysphagia in Children and Adolescents With Prader-Willi Syndrome Status COMPLETED Phase PHASE2/PHASE3
NCT05249998 Improving Care of Prader-Willi Syndrome : Evaluation of a New Care Program Combining Adapted Physical Activity, Nutrition and Therapeutic Education Status COMPLETED Phase NA
NCT05198362 Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome Status WITHDRAWN Phase PHASE2
NCT05153434 A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome Status COMPLETED Phase PHASE2
NCT05098509 A Study to Assess RAD011 (Cannabidiol Oral Solution) for the Treatment of Participants With Prader-Willi Syndrome Status TERMINATED Phase PHASE2/PHASE3
NCT05032326 Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial Status RECRUITING Phase PHASE3